Medical Disclaimer

Please Read This Carefully
The information published on GLP-1 SA (glp1sa.com) is provided for general informational and educational purposes only. It is not intended to be, and must not be construed as, medical advice, diagnosis, treatment recommendation, or a substitute for professional healthcare.

1. Not Medical Advice
Nothing on this Platform — including articles, news items, patient journey accounts, expert Q&A responses, newsletter content, or any other material — constitutes medical advice or a doctor-patient relationship.
GLP-1 receptor agonist medications including semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro) are prescription-only medications in South Africa. They must only be initiated, adjusted, or discontinued under the supervision of a registered medical practitioner.

Do not start, stop, or change the dosage of any medication based on information you have read on this Platform.

2. Consult a Qualified Healthcare Provider
Before making any decision about your health, medication, or treatment, you should:
• Consult a registered medical practitioner, pharmacist, or other qualified healthcare professional
• Disclose your full medical history, including all current medications
• Seek a second opinion if you are uncertain about any advice you receive

If you are experiencing a medical emergency, call 10177 (Emergency Medical Services in South Africa) or go to your nearest emergency department immediately.

3. No Endorsement of Specific Products or Providers
References to specific medications, medical aids, pharmacies, compounding pharmacies, or healthcare providers on this Platform do not constitute an endorsement. Mention of a product or service does not mean we recommend it for your individual circumstances.

The access and cost information on this Platform reflects general publicly available information and may not be current. Medical aid formularies, pricing, and availability change frequently. Always verify with your medical aid, prescribing doctor, or pharmacist.

4. Compounded GLP-1 Medications
Some content on this Platform discusses compounded GLP-1 medications. Compounded medications are not approved by the South African Health Products Regulatory Authority (SAHPRA) in the same manner as registered medicines. Their safety, efficacy, and quality standards may differ from registered products.

Information about compounded GLP-1 medications is provided for educational purposes to help patients understand the landscape — not to encourage or facilitate their use. We strongly recommend that any decision about compounded medications be made in consultation with a registered medical practitioner.

5. Accuracy of Information
We make reasonable efforts to ensure that the information on this Platform is accurate, evidence-based, and current at the time of publication. However, medical knowledge evolves rapidly. Information that was accurate at the time of writing may become outdated.

We cite our sources for factual and clinical claims. We encourage you to read those sources directly and to discuss them with your healthcare provider.

6. Patient Journey Accounts
The Platform includes first-person accounts from individuals sharing their experiences with GLP-1 medications. These accounts reflect individual experiences only. Individual responses to medication vary significantly. The experiences described may not be representative of what you will experience.

Patient accounts are published with consent. Names or identifying details may have been changed to protect privacy.

7. Limitation of Liability for Health Decisions
GLP-1 SA and its operators expressly disclaim any liability for any harm, loss, injury, or adverse outcome — including physical, psychological, or financial — that may result from any action taken or not taken based on content published on this Platform.

By using this Platform, you acknowledge that you understand this disclaimer and that you accept full responsibility for your own healthcare decisions.

8. Regulatory Context — South Africa
This Platform operates in the South African healthcare and regulatory context. References to regulatory agencies include SAHPRA (South African Health Products Regulatory Authority), the Health Professions Council of South Africa (HPCSA), and the Council for Medical Schemes (CMS). Regulatory information is provided for educational purposes and may change. Always verify current regulations with the relevant authority.

9. Contact
If you believe any content on this Platform contains a factual error or is potentially harmful, please contact us at info@glp1sa.com so we can review and correct it.